Analysis finds ties between pharmaceutical industry and federal government are deepening; Mississippi readies a Medicaid work requirement waiver; research identifies danger of interactions between herbal supplements and prescription medications.
An analysis from Kaiser Health News found that the ties between the pharmaceutical industry and the federal government are deepening. Alex Azar, the newly confirmed HHS secretary, is just the latest example of the so-called “revolving door” connecting the federal government and the drug industry. There are more than 300 former congressional staffers who work for pharma companies or a pharma lobbying firm and nearly a dozen former employees of the drug industry now work for the government.
Although Medicaid beneficiaries in Kentucky just sued the government over new work requirements to receive benefits, Mississippi is preparing its own waiver request to implement the same restriction. According to The Hill, the state is seeking a 5-year waiver to require able-bodied adults to participate in at least 20 hours of workforce training every week. If beneficiaries aren’t participating in approved activities, such as working, volunteering, or enrolled in a drug treatment program, they will be kicked off Medicaid. Mississippi’s waiver request differs from Kentucky, which had expanded Medicaid and targeted its requirements at those newly eligible beneficiaries.
New research has found that mixing common herbal supplements with prescription medications can result in dangerous interactions. TIME reported that the challenge is that people often don’t tell their healthcare providers what over-the-counter drugs and supplements they take. Herbals supplements can result in medications being less effective. The research found that of 49 cases of adverse drug reactions reviewed, herb—drug interactions were probable for 51%.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More